SAU:4005

National Medical Care Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:39 UTC

Last close

n/aSAR

Market data

14.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed
- Computed from the filing for 2025
16.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
19.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.36Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed

What it pays out is the furthest below its sector's middle: 0.40 against 0.44 on the market's range.

All from 100

lens 2 of 9

Sales

182

2015-12-31 to 2025-12-31100 at the start182

Sales: 100.00 on 2015-12-31 to 182.09 on 2025-12-31, up 82%.

Profit

243

2015-12-31 to 2025-12-31100 at the start243

Profit: 100.00 on 2015-12-31 to 243.27 on 2025-12-31, up 143%.

Shares in issue

99.3

2015-12-31 to 2025-12-31100 at the start99.3

Shares in issue: 100.00 on 2015-12-31 to 99.29 on 2025-12-31, down 1%.

Sales is at 182, Profit is at 243, Shares in issue is at 99, against 100 in 2015.

Sales is at 182, Profit is at 243, Shares in issue is at 99, against 100 in 2015.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100182
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
Profit, where the first year is 100243
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
Shares in issue, where the first year is 10099
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR